Semaglutide helps by increasing insulin secretion, reducing glucagon release, and slowing gastric emptying
The really profound thing, he said, was to make the next leap and ask, What does GLP-1 actually do? There were a couple of groups of researchers, some in Boston and some in Denmark, who jumped
Patients without a gallbladder can therefore expect similar efficacy in terms of weight loss and metabolic benefits
The clinical impact of this reduced susceptibility is unknown
The effect of oxyntomodulin on body weight and BAT temperature is not evident in mice that lack the GLP-1R highlighting a GLP-1R dependent action
This surge reflects recognition that GLP-1 therapy addresses the underlying biology of appetite regulation rather than relying solely on behavioral modification